Molbio Diagnostics shares list at 21% premium over IPO price on NSE, BSE

Home Markets Tools News Corporate Actions Stock Scanner Mutual Funds IPO Dashboard Portfolio Watchlist

← Back to news

Loading article...

Smart Investing Starts Here.

About Privacy Terms Financial disclaimer Contact

MarketLence on WhatsApp

Get newly published articles

Only MarketLence article alerts. You can reply STOP at any time.

I agree to receive MarketLence article notifications on WhatsApp and understand that I can unsubscribe at any time.

© 2026 MarketLence. All rights reserved.

Molbio Diagnostics shares list at 21% premium over IPO price on NSE, BSE